161 related articles for article (PubMed ID: 25315779)
1. Presynaptic control of glycine transporter 2 (GlyT2) by physical and functional association with plasma membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ exchanger (NCX).
de Juan-Sanz J; Núñez E; Zafra F; Berrocal M; Corbacho I; Ibáñez I; Arribas-González E; Marcos D; López-Corcuera B; Mata AM; Aragón C
J Biol Chem; 2014 Dec; 289(49):34308-24. PubMed ID: 25315779
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2.
de la Rocha-Muñoz A; Núñez E; Arribas-González E; López-Corcuera B; Aragón C; de Juan-Sanz J
Sci Rep; 2019 Oct; 9(1):14944. PubMed ID: 31628376
[TBL] [Abstract][Full Text] [Related]
3. Calcium regulation in individual peripheral sensory nerve terminals of the rat.
Gover TD; Moreira TH; Kao JP; Weinreich D
J Physiol; 2007 Jan; 578(Pt 2):481-90. PubMed ID: 17095566
[TBL] [Abstract][Full Text] [Related]
4. A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.
Giménez C; Pérez-Siles G; Martínez-Villarreal J; Arribas-González E; Jiménez E; Núñez E; de Juan-Sanz J; Fernández-Sánchez E; García-Tardón N; Ibáñez I; Romanelli V; Nevado J; James VM; Topf M; Chung SK; Thomas RH; Desviat LR; Aragón C; Zafra F; Rees MI; Lapunzina P; Harvey RJ; López-Corcuera B
J Biol Chem; 2012 Aug; 287(34):28986-9002. PubMed ID: 22753417
[TBL] [Abstract][Full Text] [Related]
5. Identification of a 3rd Na+ Binding Site of the Glycine Transporter, GlyT2.
Subramanian N; Scopelitti AJ; Carland JE; Ryan RM; O'Mara ML; Vandenberg RJ
PLoS One; 2016; 11(6):e0157583. PubMed ID: 27337045
[TBL] [Abstract][Full Text] [Related]
6. Calnexin-assisted biogenesis of the neuronal glycine transporter 2 (GlyT2).
Arribas-González E; Alonso-Torres P; Aragón C; López-Corcuera B
PLoS One; 2013; 8(5):e63230. PubMed ID: 23650557
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
Carta E; Chung SK; James VM; Robinson A; Gill JL; Remy N; Vanbellinghen JF; Drew CJ; Cagdas S; Cameron D; Cowan FM; Del Toro M; Graham GE; Manzur AY; Masri A; Rivera S; Scalais E; Shiang R; Sinclair K; Stuart CA; Tijssen MA; Wise G; Zuberi SM; Harvey K; Pearce BR; Topf M; Thomas RH; Supplisson S; Rees MI; Harvey RJ
J Biol Chem; 2012 Aug; 287(34):28975-85. PubMed ID: 22700964
[TBL] [Abstract][Full Text] [Related]
8. Reduced Plasma-Membrane Calcium ATPase Activity and Extracellular Acidification Trigger Presynaptic Homeostatic Potentiation at the Mouse Neuromuscular Junction.
Imomnazarov K; Torrence SE; Lindgren CA
Neuroscience; 2023 Nov; 532():103-112. PubMed ID: 37778690
[TBL] [Abstract][Full Text] [Related]
9. MS Binding Assays for Glycine Transporter 2 (GlyT2) Employing Org25543 as Reporter Ligand.
Ackermann TM; Allmendinger L; Höfner G; Wanner KT
ChemMedChem; 2021 Jan; 16(1):199-215. PubMed ID: 32734692
[TBL] [Abstract][Full Text] [Related]
10. Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2.
Frangos ZJ; Wilson KA; Aitken HM; Cantwell Chater R; Vandenberg RJ; O'Mara ML
Life Sci Alliance; 2023 Apr; 6(4):. PubMed ID: 36690444
[TBL] [Abstract][Full Text] [Related]
11. Startle Disease: New Molecular Insights into an Old Neurological Disorder.
Schaefer N; Harvey RJ; Villmann C
Neuroscientist; 2023 Dec; 29(6):767-781. PubMed ID: 35754344
[TBL] [Abstract][Full Text] [Related]
12. Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics.
Mostyn SN; Wilson KA; Schumann-Gillett A; Frangos ZJ; Shimmon S; Rawling T; Ryan RM; O'Mara ML; Vandenberg RJ
Elife; 2019 Oct; 8():. PubMed ID: 31621581
[TBL] [Abstract][Full Text] [Related]
13. Apical localization of PMCA2w/b is lipid raft-dependent.
Xiong Y; Antalffy G; Enyedi A; Strehler EE
Biochem Biophys Res Commun; 2009 Jun; 384(1):32-6. PubMed ID: 19379709
[TBL] [Abstract][Full Text] [Related]
14. Plasma membrane calcium ATPases as novel candidates for therapeutic agent development.
Strehler EE
J Pharm Pharm Sci; 2013; 16(2):190-206. PubMed ID: 23958189
[TBL] [Abstract][Full Text] [Related]
15. The
Girotto GL; Vicente CT; Miryam P; Susana B; Alberto PJ; Armando VR; Max S; Manuel M
Med Res Arch; 2020 May; 8(5):. PubMed ID: 37229357
[TBL] [Abstract][Full Text] [Related]
16. A mechanistic model of calcium homeostasis leading to occurrence and propagation of secondary brain injury.
Song JL; Westover MB; Zhang R
J Neurophysiol; 2022 Nov; 128(5):1168-1180. PubMed ID: 36197012
[TBL] [Abstract][Full Text] [Related]
17. Calcium Microdomain Formation at the Perisynaptic Cradle Due to NCX Reversal: A Computational Study.
Wade JJ; Breslin K; Wong-Lin K; Harkin J; Flanagan B; Van Zalinge H; Hall S; Dallas M; Bithell A; Verkhratsky A; McDaid L
Front Cell Neurosci; 2019; 13():185. PubMed ID: 31133809
[TBL] [Abstract][Full Text] [Related]
18. Shed CNTNAP2 ectodomain is detectable in CSF and regulates Ca
Martín-de-Saavedra MD; Dos Santos M; Culotta L; Varea O; Spielman BP; Parnell E; Forrest MP; Gao R; Yoon S; McCoig E; Jalloul HA; Myczek K; Khalatyan N; Hall EA; Turk LS; Sanz-Clemente A; Comoletti D; Lichtenthaler SF; Burgdorf JS; Barbolina MV; Savas JN; Penzes P
Neuron; 2022 Feb; 110(4):627-643.e9. PubMed ID: 34921780
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of the analgesic GlyT2 inhibitor, ORG25543, is determined by two connected allosteric sites.
Chater RC; Quinn AS; Wilson K; Frangos ZJ; Sutton P; Jayakumar S; Cioffi CL; O'Mara ML; Vandenberg RJ
J Neurochem; 2023 Dec; ():. PubMed ID: 38131125
[TBL] [Abstract][Full Text] [Related]
20. Correlation of calpain sensitivity, Bradford assay instability, and electrophoretic mobility in phosphomimetic mutants of GlyT2 N-terminus.
Baliova M; Jursky F
Biochem Biophys Rep; 2024 Jul; 38():101734. PubMed ID: 38799113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
